Navigation Links
Amylin Comments on RiskMetrics Report
Date:5/15/2009

Urges Stockholders to Vote FOR Amylin Director Nominees on the Blue Proxy Card Today

RiskMetrics Splits Recommendation in Proxy Contest

SAN DIEGO, May 15 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today issued the following statement in response to a report issued by RiskMetrics Group (formerly Institutional Shareholder Services) regarding Amylin's Annual Meeting of Stockholders to be held on May 27, 2009:

It is important for shareholders to note that RiskMetrics split its recommendation, supporting only three out of five nominees proposed by Carl Icahn and Eastbourne Capital Management, L.L.C. We are confident that our slate of nominees is the right Board to lead Amylin. We are disappointed that RiskMetrics has recommended three dissident nominees to our annually-elected Board. The Company urges shareholders to vote FOR Amylin's highly-qualified Director nominees who have extensive experience in biopharmaceuticals and diabetes, as well as the valuable sales and marketing expertise necessary to most effectively guide Amylin. We believe that our nominees have better qualifications relevant to our business.

Importantly, Amylin's Board and management team have recognized and embraced the need for change, with two new independent Director nominees, Paul N. Clark, former Chairman, Chief Executive Officer and President of Icos Corporation, and Paulo F. Costa, former President and Chief Executive Officer of Novartis U.S. Corporation. Both bring additional commercial and operational expertise in the biopharmaceutical industry, which are key attributes requested by our shareholders.

Over the course of the past six months, Amylin has also taken the necessary steps to effect change in its business strategy and increase long-term shareholder value, including:
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Amylin Pharmaceuticals to Present at Deutsche Bank Health Care Conference
2. Amylin Co-Founder Announces Plans to Vote for Eastbourne Slate
3. Amylin Pharmaceuticals Announces a New Sales Approach to Better Target the Diabetes Market
4. Amylin Issues Statement in Response to Carl Icahn
5. Icahn Asks Amylin to Allow Discussions With Eastbourne
6. Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments
7. Amylin Pharmaceuticals to Present at Cowen and Company Annual Health Care Conference
8. Amylin Pharmaceuticals Confirms Receipt of Director Nomination Notices
9. Amylin Pharmaceuticals Appoints Vincent Mihalik Senior Vice President, Sales and Marketing and Chief Commercial Officer
10. Amylin Pharmaceuticals Highlights 2009 Value Creation Opportunities
11. Amylin Pharmaceuticals Announces Strategic Restructuring and Workforce Reduction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... BRISBANE, Calif. , July 28, 2014  InterMune, ... it will release its second quarter 2014 financial results ... August 6, 2014. A live conference call and webcast will ... that same day. Interested investors and others ... (U.S.) or +1 212-231-2900 (international), conference ID#21728775. A replay of ...
(Date:7/26/2014)... Canada Endoscopy Visualization Systems Market Outlook ... Canada Endoscopy Visualization Systems market. The report provides ... units) and average prices (in US dollars) within ... Endoscopy Visualization Systems and Low-End Endoscopy Visualization Systems. ... , The report also provides company shares and ...
(Date:7/25/2014)... from the University of Leicester has furthered our ... potential to create new materials using nanosized ,building ... in the prestigious academic journal Physical Review ... examine in rich detail the structure and internal ... acetylene molecule and a single helium atom. , ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 The Conferee ... for Topics for Conferee Networking. These two-hour sessions provide ... to meet and resolve problems, discuss new techniques, or ... deadline to submit a topic for consideration is August ... pittcon.org . The Conferee Networking committee will review the ...
Breaking Biology Technology:InterMune to Release Second Quarter Financial Results on August 6 2Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 2Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 3Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 4Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 5Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 2Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 3Pittcon 2015 Announces Call for Topics for Conferee Networking Sessions 2
... ... to quickly and accurately forecast, plan and respond to ever-changing market demands, ManufacturingOne meets ... ... In response to a growing customer base in the high-tech manufacturing segment, YASH ...
... ... to give employees more ‘real time’ feedback. Employee development is a priority at Merrimack, ... million Massachusetts Life Sciences Center tax incentive award for job creation. , ... Cambridge, Mass (PRWEB) March 24, 2010 -- Merrimack ...
... of larger effort to develop and distribute high-quality experimental tools that will speed progress toward better treatments for PD -- , ... , , ... ... ...
Cached Biology Technology:YASH Technologies™ Launches ManufacturingOne, a Qualified SAP Business All-in-One Partner Solution for the High-tech Manufacturing Industry 2YASH Technologies™ Launches ManufacturingOne, a Qualified SAP Business All-in-One Partner Solution for the High-tech Manufacturing Industry 3YASH Technologies™ Launches ManufacturingOne, a Qualified SAP Business All-in-One Partner Solution for the High-tech Manufacturing Industry 4Merrimack Pharmaceuticals Recognized for Innovative Talent Management in HR Executive Magazine's ‘Best HR Ideas for 2010' Issue 2Michael J. Fox Foundation Offers High-Quality LRRK2 Antibodies for PD Therapeutic Development 2Michael J. Fox Foundation Offers High-Quality LRRK2 Antibodies for PD Therapeutic Development 3Michael J. Fox Foundation Offers High-Quality LRRK2 Antibodies for PD Therapeutic Development 4
(Date:7/28/2014)... Research and Markets has announced ... America 2014-2018" report to their offering. ... and analyze biological data. These systems capture biological traits ... patterns, and hand measurements from the subject and compare ... main purpose of a biometrics system is to identify ...
(Date:7/28/2014)... Institute for Biologically Inspired Engineering at Harvard University ... be commercialized by a newly formed private company ... personalized medicine products. The announcement follows ... Technology Development (OTD) and the start-up Emulate Inc., ... human Organs-on-Chips platform. , "This is a ...
(Date:7/27/2014)... revealed that nicotine and cotinine, a metabolite of nicotine, ... carcinogen in smoke. , The carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone or NNK ... ultimately ends up in the tobacco smoke. Once inhaled, ... it is activated by a variety of enzymes called ... that nicotine can partially interfere with the activation of ...
Breaking Biology News(10 mins):Biometrics Market in Latin America 2014-2018 2Wyss Institute's technology translation engine launches 'Organs-on-Chips' company 2Wyss Institute's technology translation engine launches 'Organs-on-Chips' company 3Nicotine found to inhibit DNA-strand break caused by a certain carcinogen in smoke 2
... Lombardini has gone underground to get the most top ... roots grow in his experimental orchards, and it is ... His study is part of a national specialty crop ... Lombardini, a Texas AgriLife Research horticultural scientist, will focus ...
... As climate change causes temperatures to increase in ... also creep up the mountains, invading most of ... group of endangered and remarkable birds. ... the likelihood of a forthcoming "disease invasion" by ...
... Scientists from around the world will convene at the ... key findings from the most ambitious effort ever undertaken ... determine how they contribute in the near term to ... The two-year international field campaign known as POLARCAT ...
Cached Biology News:Getting to the root of science in a nutty way 2Jeepers creepers: Climate change threatens endangered honeycreepers 2Jeepers creepers: Climate change threatens endangered honeycreepers 3Spring agricultural fires have large impact on melting Arctic 2Spring agricultural fires have large impact on melting Arctic 3
... monoclonal [6331] to Salmonella typhimurium The genus ... The genus is composed of Gram-negative bacilli that ... major antigens; the "H" or flagellar antigen (phase ... (part of the LPS moiety) and the "Vi" ...
... sodium pyruvate, 50 mg/L streptomycin sulfate, 100 ... chloride, and magnesium chloride. The use of ... culture is generally attributed to early workers ... developed a solution of inorganic salts designed ...
... is a dramatic breakthrough in accurate, small-volume bulk ... resolution, the micro 1 has unique advantages not ... micro 1 never needs re-calibration as do other ... on an LCD Display , Graphical Row Selection ...
... ( Abpromise for all tested ... Synthetic peptide: VEEESFGPQPISRLE conjugated to KLH, ... 15-29 of Human Rad51 ... Swiss Protein ID: ...
Biology Products: